1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024

  • March 2016
  • 64 pages
  • GlobalData
Report ID: 3716491

Summary

Table of Contents

Search Inside

EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024

Summary

Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings of emotional highs (mania or hypomania) and lows (depression). In between episodes of mood swings, patients typically return to their regular state of being. During a manic or depressive episode, the disease can be debilitating, severely affecting a person’s ability to perform on the job or maintain good relationships with other people.

In 2014, there were 13,808,283 12-month and 23,140,488 lifetime total prevalent cases of bipolar disorder in the 8MM. In 2014, of the lifetime total prevalent cases, 52.15% were cyclothymic disorder, 24.58% bipolar I, and 23.27% bipolar II. GlobalData epidemiologists forecast that there will be approximately 14,703,622 12-month and 24,616,577 lifetime total prevalent cases of bipolar disorder in 2024.

In this report, GlobalData epidemiologists provide the forecast for the 12-month and lifetime total prevalent cases (both diagnosed and undiagnosed) of bipolar disorder spectrum in the 8MM. GlobalData epidemiologists sourced robust data based on national and international epidemiological studies and strong regional level studies. Age- and sex-specific rates were used whenever available. GlobalData epidemiologists used a consistent disease definition as well as consistent forecast methodology across all the 8MM to allow for a meaningful comparison among them.

Scope

- The Bipolar EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for bipolar spectrum disorder in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10-year epidemiological forecast for both 12-month and lifetime total prevalent cases of bipolar I, bipolar II, and cyclothymic disorder segmented by sex and age in these markets.
- The bipolar epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Bipolar EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global bipolar market.
- Quantify patient populations in the global bipolar market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for bipolar therapeutics in each of the markets covered.
- Identify the subtype of bipolar disorder spectrum most important to your market plans.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Bipolar Disorder Therapeutic Market 2017-2021

  • $ 3500
  • Industry report
  • April 2017
  • by Infiniti Research Limited

About Bipolar Disorder Therapeutic Bipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and ...

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • April 2017
  • by GlobalData

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017" ...

Global Bipolar Disorder Partnering 2010 - 2017

  • $ 1495
  • Industry report
  • April 2017
  • by Currentpartnering

Provides understanding and access to the bipolar disorder partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Bipolar Disorder Partnering Terms ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.